CRWD vs DHR: Which Is the Better Buy?
Side-by-side comparison of CrowdStrike Holdings, Inc. and Danaher Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-10.
CrowdStrike Holdings, Inc. · Technology
$191.12
+32.7% upside to fair value
Grade B
VS
Danaher Corporation · Healthcare
$195.98
+7.9% upside to fair value
Grade B
High Quality
QuantHub Verdict
CRWD has more upside to fair value
(+32.7%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
CRWD |
DHR |
| Current Price |
$191.12 |
$195.98 |
| Fair Value Estimate |
$253.64 |
$211.54 |
| Upside to Fair Value |
+32.7%
|
+7.9%
|
| Market Cap |
$194.6B |
$138.7B |
| Forward P/E |
-4023.6x
|
37.8x
|
| EV / EBITDA |
570.3x
|
22.8x
|
| Price / Sales |
38.2x
|
5.6x
|
| Price / FCF |
134.0x
|
26.2x
|
| Revenue Growth YoY |
+25.6%
|
+3.7%
|
| Gross Margin |
75.0%
|
60.7%
|
| Operating Margin |
-3.9%
|
21.0%
|
| Return on Equity |
-0.6%
|
7.1%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
0.75%
|
3.81%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
CrowdStrike Holdings, Inc. operates in the technology sector, specifically in software infrastructure, providing cybersecurity solutions. The business quality is medium due to its strong revenue growth of 25.6% in the most recent quarter and impressive earnings growth of 125.2% in the same period, indicating effective scaling and operational leverage. However, profitability metrics remain challen…
Danaher Corporation operates in the healthcare sector, specifically in medical diagnostics and research, delivering high-quality products with a durable competitive moat supported by strong margins and consistent earnings growth. The company trades at a trailing and forward P/E of 37.76, which is relatively high but justified by its stable revenue growth of 3.7% and earnings growth of 7.9% in the…
Accumulation Zones
| Metric |
CRWD |
DHR |
| Zone Low |
$190.23 |
$158.66 |
| Zone High |
$215.59 |
$179.81 |
| In Buy Zone? |
Yes
|
No
|